Abstract
Malignant pleural effusion represents advanced disease. Management is determined by the patient’s performance status, symptoms and degree of lung re expansion after pleural fluid drainage. The goal of management is control of patient symptoms, with minimum morbidity and maximum patient independence. Pleural fluid evacuation and long term palliation can be achieved by either chemical pleurodesis or patient controlled drainage with a tunneled pleural catheter. Thoughtful patient evaluation is critical to choosing the appropriate palliative option for each individual with malignant pleural effusion.
Keywords: Malignant effusions, pleurodesis, thoracoscopy, tunneled pleural catheter, Decortications, neoplasm, PLEURAL LINING, mesothelial layer, endothelial, fibroblasts, pleural fluid.
Current Respiratory Medicine Reviews
Title:Malignant Pleural Effusion Evaluation and Management
Volume: 8 Issue: 4
Author(s): Jed A. Gorden and Joelle Thirsk Fathi
Affiliation:
Keywords: Malignant effusions, pleurodesis, thoracoscopy, tunneled pleural catheter, Decortications, neoplasm, PLEURAL LINING, mesothelial layer, endothelial, fibroblasts, pleural fluid.
Abstract: Malignant pleural effusion represents advanced disease. Management is determined by the patient’s performance status, symptoms and degree of lung re expansion after pleural fluid drainage. The goal of management is control of patient symptoms, with minimum morbidity and maximum patient independence. Pleural fluid evacuation and long term palliation can be achieved by either chemical pleurodesis or patient controlled drainage with a tunneled pleural catheter. Thoughtful patient evaluation is critical to choosing the appropriate palliative option for each individual with malignant pleural effusion.
Export Options
About this article
Cite this article as:
A. Gorden Jed and Thirsk Fathi Joelle, Malignant Pleural Effusion Evaluation and Management, Current Respiratory Medicine Reviews 2012; 8 (4) . https://dx.doi.org/10.2174/157339812802652170
DOI https://dx.doi.org/10.2174/157339812802652170 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antagonists of Growth Hormone-Releasing Hormone in Oncology
Combinatorial Chemistry & High Throughput Screening Three-Dimensional Ultrasound in Soft Tissue Tumor Imaging
Current Medical Imaging Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1
Current Gene Therapy The Role of CD8+ T Cell Soluble Factors in Human Immunodeficiency Virus Infection
Current Medicinal Chemistry Colorectal Carcinogensis and Suppression of Tumor Development by Inhibition of Enzymes and Molecular Targets
Current Enzyme Inhibition Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease
Current Alzheimer Research Acridones As Antiviral Agents: Synthesis, Chemical and Biological Properties
Current Medicinal Chemistry Intrinsic Disorder in Male Sex Determination: Disorderedness of Proteins from the Sry Transcriptional Network
Current Protein & Peptide Science Therapeutic Potential of γ -Secretase Inhibitors and Modulators
Current Topics in Medicinal Chemistry Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry CXCR4 Receptor as a Promising Target for Oncolytic Drugs
Mini-Reviews in Medicinal Chemistry Combining Gene Therapy and Radiation Against Cancer
Current Gene Therapy siRNA Modifications and Sub-Cellular Localization: A Question of Intracellular Transport?
Current Pharmaceutical Design Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design The Signal Pathway of Antibiotic Alternatives on Intestinal Microbiota and Immune Function
Current Protein & Peptide Science Patent Selections
Recent Patents on Drug Delivery & Formulation Mechanisms of Tumor Cell Necrosis
Current Pharmaceutical Design